Concentric Capital Strategies’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-77,323
Closed -$401K 367
2025
Q3
$401K Buy
+77,323
New +$445K 0.02% 276
2024
Q2
Sell
-146,637
Closed -$1.75M 383
2024
Q1
$1.75M Buy
+146,637
New +$1.63M 0.1% 209

Other funds holding PTEN

Concentric Capital Strategies's PTEN Position: Q4 2025 in Review

Concentric Capital Strategies sold out of Patterson-UTI (PTEN) in Q4 2025, closing a stake of 77,323 shares — an estimated $401K sold.

Concentric Capital Strategies first reported a position in PTEN in Q1 2024 and held it in 2 quarters. The position peaked at $1.75M in Q1 2024. 372 funds tracked by Wall St. Rank hold PTEN as of Q4 2025.

  • Concentric Capital Strategies reported no remaining Patterson-UTI position as of Q4 2025 after selling out during the quarter.
  • Concentric Capital Strategies sold 77,323 Patterson-UTI shares in Q4 2025, an estimated $401K.
  • Concentric Capital Strategies first reported a position in Patterson-UTI in Q1 2024 and held it in 2 quarters.
  • Concentric Capital Strategies's Patterson-UTI position peaked at $1.75M in Q1 2024.
  • 372 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2025.

Based on Concentric Capital Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.